Literature DB >> 24081766

Amikacin treatment for multidrug resistant tuberculosis: how much monitoring is required?

Veronica Melchionda1, Harry Wyatt, Santino Capocci, Raul Garcia Medina, Angelita Solamalai, Sotira Katiri, Susan Hopkins, Ian Cropley, Marc Lipman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24081766     DOI： 10.1183/09031936.00184312

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  8 in total

Review 1.  Drug-Induced Ototoxicity: Diagnosis and Monitoring.

Authors:  Kathleen C M Campbell; Colleen G Le Prell
Journal:  Drug Saf       Date:  2018-05       Impact factor: 5.606

2.  Reduced Chance of Hearing Loss Associated with Therapeutic Drug Monitoring of Aminoglycosides in the Treatment of Multidrug-Resistant Tuberculosis.

Authors:  R van Altena; J A Dijkstra; M E van der Meer; J F Borjas Howard; J G W Kosterink; D van Soolingen; T S van der Werf; J W C Alffenaar
Journal:  Antimicrob Agents Chemother       Date:  2017-02-23       Impact factor: 5.191

3.  Adverse Effects and Choice between the Injectable Agents Amikacin and Capreomycin in Multidrug-Resistant Tuberculosis.

Authors:  Amber Arnold; Graham S Cooke; Onn Min Kon; Martin Dedicoat; Marc Lipman; Angela Loyse; Irina Chis Ster; Thomas S Harrison
Journal:  Antimicrob Agents Chemother       Date:  2017-08-24       Impact factor: 5.191

Review 4.  Quality of Life, Psychological Interventions and Treatment Outcome in Tuberculosis Patients: The Indian Scenario.

Authors:  Vidyullatha Peddireddy
Journal:  Front Psychol       Date:  2016-10-27

Review 5.  Evolution of drug resistance in Mycobacterium tuberculosis: a review on the molecular determinants of resistance and implications for personalized care.

Authors:  Navisha Dookie; Santhuri Rambaran; Nesri Padayatchi; Sharana Mahomed; Kogieleum Naidoo
Journal:  J Antimicrob Chemother       Date:  2018-05-01       Impact factor: 5.790

6.  Sequential analysis as a tool for detection of amikacin ototoxicity in the treatment of multidrug-resistant tuberculosis.

Authors:  Karla Anacleto de Vasconcelos; Silvana Maria Monte Coelho Frota; Antonio Ruffino-Netto; Afrânio Lineu Kritski
Journal:  J Bras Pneumol       Date:  2018-04       Impact factor: 2.624

7.  A longitudinal community-based ototoxicity monitoring programme and treatment effects for drug-resistant tuberculosis treatment, Western Cape.

Authors:  Lucia J Stevenson; Leigh Biagio-de Jager; Marien A Graham; De Wet Swanepoel
Journal:  S Afr J Commun Disord       Date:  2022-03-31

8.  Detection of differentially culturable tubercle bacteria in sputum from drug-resistant tuberculosis patients.

Authors:  Bhavna G Gordhan; Astika Sewcharran; Marothi Letsoalo; Thilgavathy Chinappa; Nonhlanhla Yende-Zuma; Nesri Padayatchi; Kogieleum Naidoo; Bavesh D Kana
Journal:  Front Cell Infect Microbiol       Date:  2022-09-09       Impact factor: 6.073
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.